Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 10, No 2 (2014) STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY) Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, L. Yu. Drozdova, O. V. Lerman, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yahontov
"... Aim. To assess the potential of ursodeoxycholic acid (UDCA) in the prevention of liver dysfunction ..."
 
Vol 5, No 6 (2009) STATINS AND URSODEOXYCHOLIC ACID: COOPERATION OR NEUTRALITY? Abstract  similar documents
I. N. Grigorieva, Y. M. Pozdnyakov
"... ), non-alcoholic steatohepatitis (NASH) and hypercholesterolemia (HCE) with statins and ursodeoxycholic ..."
 
Vol 11, No 3 (2015) THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY) Abstract  similar documents
N. P. Kutishenko, S. Yu. Martsevich, O. V. Lerman, I. S. Balashov, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yakhontov
"... Aim. To evaluate the differences between a group of patients treated with ursodeoxycholic acid ..."
 
Vol 12, No 3 (2016) THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT PREVENTS OVERCOMING STATINOPHOBIA? Abstract  PDF (Eng)  similar documents
S. N. Bel'diev
"... and ursodeoxycholic acid; 4) view of the inadmissibility of statin use in patients with transaminase levels more than ..."
 
Vol 13, No 1 (2017) SCHEME FOR COMBINED USE OF STATINS AND URSODEOXYCHOLIC ACID IN PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR EVENTS AND CONCOMITANT NON-ALCOHOLIC FATTY LIVER DISEASE: PROBLEMS OF PRACTICAL APPLICATION Abstract  similar documents
S. N. Bel'diev
"... of statins and ursodeoxycholic acid (UDCA) co-administration was developed in 2014 and subsequently in 2016 ..."
 
Vol 9, No 4 (2013) ACETYLSALICYLIC ACID: CONTROVERSIAL AND OUTSTANDING ISSUES Abstract  similar documents
E. N. Dankovtseva
"... Review of current ideas about the role of acetylsalicylic acid (ASA) in the primary prevention ..."
 
Vol 8, No 2 (2012) ACETYLSALICYLIC ACID IN THE PREVENTION OF ATHEROTHROMBOTIC EVENTS Abstract  similar documents
A. V. Govorin, A. P. Filev
"... of acetylsalicylic acid (ASA) in primary and secondary prevention of atherothrombotic events. Studies on the safety ..."
 
Vol 6, No 5 (2010) LONG-TERM THERAPY WITH ACETYLSALICYLIC ACID. HOW TO AVOID THE POSSIBLE COMPLICATIONS? Abstract  similar documents
I. V. Zhirov
"... Data about efficacy and safety of long-term therapy with acetylsalicylic acid in patients ..."
 
Vol 7, No 4 (2011) ON THE 125TH ANNIVERSARY OF ACETYLSALICYLIC ACID Abstract  similar documents
I. N. Bokarev, L. V. Popova
"... An experience of acetylsalicylic acid (ASA) clinical use since its synthesis in 1887 ..."
 
Vol 5, No 6 (2009) ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS Abstract  similar documents
N. A. Dmitrieva, S. N. Tolpygina
"... Data of evidence based medicine which confirm efficacy of acetylsalicylic acid (ACA ..."
 
Vol 3, No 3 (2007) RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
D. H. Aynetdinova, A. E. Udovichenko, V. A. Sulimov
"... . Key words: antiplatelet drugs, clopidogrel, resistance to acetylsalicylic acid. Rational Pharmacother ..."
 
Vol 8, No 3 (2012) MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES Abstract  similar documents
A. V. Govorin, A. P. Filev
"... intracellular penetration. Magnerot deserves attention as a complex drug consisting of magnesium and orotic acid ..."
 
Vol 8, No 4 (2012) ACETYLSALICYLIC ACID: WHAT'S NEW IN THE OLD DRUG? Abstract  similar documents
I. V. Zhirov
"... The results of recent trials on acetylsalicylic acid (ASA) efficacy are presented. Data ..."
 
Vol 8, No 5 (2012) ACETYLSALICYLIC ACID: DO WE KNOW EVERYTHING ABOUT IT AND ITS PROPER USE? Abstract  similar documents
S. A. Boldueva, I. A. Leonova
"... Use of acetylsalicylic acid (ASA) in cardiology practice is presented. ASA modes of action ..."
 
Vol 7, No 3 (2011) VALUE OF NICOTINIC ACID IN THE CURRENT CARDIOLOGY Abstract  similar documents
E. P. Trukhacheva, M. V. Ezhov
"... acid intake in these patients may be necessary for the normalization of lipid profile, including ..."
 
Vol 4, No 5 (2008) MOLECULAR MECHANISMS OF ACTION OF MAGNESIUM OROTATE ON CARDIOVASCULAR SYSTEM Abstract  similar documents
I. Yu. Torshin, O. A. Gromova
"... Orotic acid is one of the intermediates in the pyrimidine biosynthesis. Mechanisms of physiological ..."
 
Vol 8, No 2 (2012) CLINICAL IMPLICATION OF FATTY ACID CHANGES IN PATIENTS WITH PRIMARY GOUT ASSOCIATED WITH ARTERIAL HYPERTENSION Abstract  similar documents
N. N. Kushnarenko, A. V. Govorin
"... Aim. To study blood levels of non-esterified fatty acids (NEFAs) and adenyl nucleotides, and fatty ..."
 
Vol 10, No 2 (2014) HYPERURICEMIA AND ITS CORRELATES IN THE RUSSIAN POPULATION (RESULTS OF ESSE-RF EPIDEMIOLOGICAL STUDY) Abstract  similar documents
S. A. Shalnova, A. D. Deev, G. V. Artamonov, D. V. Duplyakov, A. Yu. Efanov, Yu. V. Zhernakova, A. O. Konradi, R. A. Libis, G. A. Muromtseva, S. V. Nedogoda, E. V. Oschepkova, S. V. Romanchuk, O. P. Rotar, V. N. Titov, Z. A. Toguzova, I. A. Trubacheva, G. I. Furmenko, E. V. Shlyakhto, S. A. Boytsov
"... factors are revealed. Key words: uric acid, prevalence, hyperuricemia, cardiovascular diseases, gender ..."
 
Vol 9, No 1 (2013) THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS Abstract  similar documents
A. O. Malygin, V. L. Doshchitsin
"... Antiarrhythmic effect of omega-3 polyunsaturated fatty acids (ω-3 PUFA), eicosapentaenoic ..."
 
Vol 8, No 1 (2012) OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES Abstract  similar documents
A. V. Govorin, A. P. Filev
"... For today there are convincing evidences of beneficial effect of ω-3 polyunsaturated fatty acids ..."
 
Vol 7, No 5 (2011) HOMOCYSTEINE-LOWERING THERAPY AND LONG-TERM PROGNOSIS AFTER ELECTIVE PERCUTANEOUS CORONARY INTERVENTION Abstract  similar documents
O. O. Shakhmatova, A. L. Komarov, A. N. Samko, T. I. Kotkina, D. V. Rebrikov, A. D. Deev, E. P. Panchenko
"... Background. Vitamins В6 В12 and folic acid (FA) therapy to reduce cardiovascular risk appears ..."
 
Vol 8, No 2 (2012) RESIDUAL PLATELET REACTIVITY DURING THERAPY WITH INHIBITORS OF CYCLOOXIGENASE OR ADENOSINE DIPHOSPHATE RECEPTORS Abstract  similar documents
A. A. Lomonosova, N. A. Mazur, E. A. Zolozova, E. V. Sayutina, V. V. Chigineva, N. V. Shestakova
"... Aim. To compare effects of acetylsalicylic acid (ASA) and two clopidogrel drugs on residual ..."
 
Vol 5, No 5 (2009) EFFECTS OF ACETYLSALICYLIC ACID AND CLOPIDOGREL ON MORPHOFUNCTIONAL STATUS OF ERYTHROCYTES IN PATIENTS WITH ACUTE CORONARY SYNDROME Abstract  similar documents
A. L. Alyavi, R. A. Rakhimov, B. A. Alyavi
"... and morphology of erythrocytes and to assess their changes during therapy with acetylsalicylic emacid/em, clopidogrel ..."
 
Vol 6, No 6 (2010) COMPARISON OF ANTIPLATELET EFFICACY OF ORIGINAL AND GENERIC ENTEROSOLUBLE ACETYLSALICYLIC ACID IN PATIENTS WITH HIGH CARDIOVASCULAR RISK. SIMPLE BLIND CROSSED RANDOMIZED CONTROLLED STUDY (IKAR) Abstract  similar documents
S. Yu. Martsevich, S. N. Tolpygina, E. S. Boychenko, R. E. Dubinskaya, Yu. V. Lukina, V. P. Voronina
"... acetylsalicylic emacid/em (ASA) in patients with high cardiovascular risk. Material and мethods. Patients (n=30 ..."
 
Vol 2, No 1 (2006) THE USE OF A NEW APPROACH TO PREVENTION AND THERAPY OF ACUTE ARTERIAL HYPERTENSION WITH COMPLEX OF WELL-KNOWN DRUGS WITH VEGETABLE GLYCOSIDES (EXPERIMENTAL STUDY) Abstract  similar documents
T. G. Tolstikova, I. V. Sorokina, A. O. Brisgalov, M. P. Dolgich, G. I. Lifshitz, M. V. Chvostov
"... short acting formulation while NC is a new formulation of nifedipine in complex with glycyrrhizic emacid/em ..."
 
Vol 5, No 3 (2009) ANTIPLATELET DRUGS RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE AND OBLITERATIVE ATHEROSCLEROSIS OF LOWER LIMB ARTERIES ASSOCIATED WITH DIABETES MELLITUS TYPE 2 Abstract  similar documents
E. V. Gorjacheva, A. E. Udovichenko, V. A. Sulimov, N. V. Lavrishcheva, M. A. Surikova, T. N. Gracheva
"... Aim. To study a rate of resistance to acetylsalicylic emacid/em (ASA) and clopidogrel and clinical ..."
 
Vol 7, No 2 (2011) PECULIAR PROPERTIES OF ANTITHROMBOTIC THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION. IS IT POSSIBLE TO DO THE TREATMENT SAFE? Abstract  similar documents
I. V. Zotova, D. A. Zateyshchikov
"... fibrillation, acetylsalicylic emacid/em, warfarin, atherothrombosis. Rational Pharmacother. Card. 2011;7(2):219-226 ..."
 
Vol 4, No 1 (2008) COMPARISON OF ANTIPLATELET EFFECT AND SAFETY OF ORIGINAL DRUG «ASPIRIN CARDIO» AND GENERIC«ACECARDOL» IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE Abstract  similar documents
N. A. Belolipetskiy, S. N. Tolpygina, O. А. Litinskaya, V. G. Belolipetskaya, S. Yu. Martsevich
"... Aim. To compare antiplatelet effect of two acetylsalicylic emacid/em medicines, Acecardol ("Synthesis ..."
 
Vol 4, No 2 (2008) ANTIPLATELET THERAPY RESISTANCE IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION Abstract  similar documents
D. H. Ainetdinova, A. Е. Udovichenko, V. A. Sulimov
"... Aim. To evaluate the incidence of acetylsalicylic emacid/em (ASA) and clopidogrel resistance ..."
 
Vol 12, No 3 (2016) MEMBRANE BILE ACID RECEPTOR TGR5 - A NEW TARGET IN THE STUDY OF METABOLIC, INFLAMMATORY AND NEOPLASTIC DISEASES Abstract  PDF (Eng)  similar documents
O. M. Drapkina, E. I. Fomicheva
"... TGR5 are G-protein-linked, membrane bile emacids/em receptors that widely express in tissues of animals ..."
 
Vol 12, No 5 (2016) Features of the Hemostasis and Platelets Enzyme Activity in Patients with Different Sensitivity to Acetylsalicylic Acid by the Acute Coronary Syndrome Abstract  similar documents
I. Yu. Grinshtein, A. A. Savchenko, Yu. I. Grinshtein, M. M. Petrova
"... in acetylsalicylic emacid/em (ASA) sensitive and resistant patients with acute coronary syndrome (ACS). Material ..."
 
Vol 12, No 4 (2016) High residual platelet reactivity during dual antiplatelet therapy, found by optical aggregometry and the rate of atherothrombotic complications after coronary artery stenting in patients with ischemic heart disease in clinical practice Abstract  similar documents
N. F. Puchinyan, N. V. Furman, P. V. Dolotovskaya, L. L. Malinova
"... antiplatelet therapy (DAT) with acetylsalicylic emacid/em (ASA) and clopidogrel by optical aggregometry in patients ..."
 
Vol 11, No 1 (2015) CLINICAL CASE OF RUSSIAN THROMBOLYTIC AGENT FORTELYZIN® USE IN PATIENTS WITH ACUTE CORONARY ARTERY DISEASE Abstract  similar documents
K. A. Kireev, A. V. Krasnopeev, S. V. Utkina
"... recombinant protein comprising an amino emacid/em sequence of staphylokinase is described. The trial was held ..."
 
Vol 10, No 3 (2014) COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION Abstract  similar documents
A. V. Rudakova, V. A. Parfenov
"... K antagonists (such as warfarin), antiplatelet therapy (such as acetylsalicylic emacid/em) and novel oral ..."
 
Vol 8, No 3 (2012) THE EFFICACY OF COMBINED BIOMARKER TESTS IN EARLY DIAGNOSTICS OF ACUTE MYOCARDIAL INFARCTION AFTER CLINICAL SYMPTOMS ONSET: ROLE OF HEART-TYPE FATTY ACID-BINDING PROTEIN Abstract  similar documents
O. V. Baturina, S. R. Gilyarevsky, I. M. Kuzmina, M. A. Godkov, E. V. Klychnikova
"... Aim. To evaluate the diagnostic value of heart-type fatty emacid/em-binding protein (H-FABP ..."
 
Vol 3, No 4 (2007) RESISTANCE TO ACETYLSALICYLIC ACID AND PREVALENCE OF THROMBOSIS IN PATIENTS WITH STABLE ANGINA Abstract  similar documents
N. F. Putchinyan, N. V. Furman, P. Ya. Dovgalevskyi
"... sensitivity to acetylsalicylic emacids/em (ASA) in patients with stable angina. Material and methods. 96 patients ..."
 
Vol 6, No 2 (2010) EFFICACY AND SAFETY OF ACIDUM ACETYLSALICYLICUM USAGE Abstract  similar documents
V. N. Drozdov, V. A. Kim
"... Data about efficacy and safety of acetylsalicylic emacid/em usage as antiplatelet drug and for cancer ..."
 
Vol 8, No 2 (2012) THE "NEW" DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASE Abstract  similar documents
S. N. Tereshchenko, I. V. Zhirov, A. G. Kochetov, O. V. Uspenskaya
"... A comparison of ivabradine and omega-3 polyunsaturated fatty emacids/em, drugs with principally ..."
 
Vol 7, No 5 (2011) DIETARY FATTY ACIDS. EFFECTS ON THE RISK OF CARDIOVASCULAR DISEASES Abstract  similar documents
N. V. Perova, V. A. Metel'skaya, E. I. Sokolov, G. N. Shchukina, V. M. Fomina
"... The world publications data about the impact of consumption and the fatty emacids/em ratio in consumed ..."
 
Vol 6, No 3 (2010) CLINICAL SIGNIFICANCE OF ANEMIC SYNDROME IN PATIENTS WITH CHRONIC HEART FAILURE Abstract  similar documents
V. N. Larina, B. Ya. Bart, V. G. Larin
"... , vitamin B12 or folic emacid/em was a reason of anemia in 35,8%, 9,4% and 15,1% of patients, respectively ..."
 
Vol 2, No 3 (2006) ANTITHROMBOTIC THERAPY OF ISCHEMIC HEART DISEASE: FROM FAST ACTING ANTIAGGREGANTS TO STATINES AND NITRATE OXIDE. IS IT REAL? Abstract  similar documents
I. A. Latfullin, A. A. Podolskaya
"... of action and clinical efficiency of antithrombotic and antiplatelet medicines such as acetylsalicylic emacid/em ..."
 
Vol 2, No 3 (2006) NEW EVIDENCES OF POSSIBILITY OF OMEGA-3 ACIDS USE FOR MYOCARDIAL INFARCTION SECONDARY PREVENTION Abstract  similar documents
A. I. Martinov, V. L. Chomenko
"... fatty emacids/em (PUFAs) were analyzed. It was proved that PUFAs class omega-3 have positive effects ..."
 
Vol 5, No 4 (2009) GASTROENTEROPATHIES ASSOCIATED WITH ACETYLSALICYLIC ACID: HOW TO IMPROVE SAFETY OF THERAPY Abstract  similar documents
A. L. Komarov
"... Lesion of gastrointestinal mucous coat is the main factor limited acetylsalicylic emacid/em (ASA) use ..."
 
Vol 4, No 3 (2008) OMEGA-3 POLYUNSATURATED FATTY ACIDS IN ATRIAL FIBRILLATION PREVENTION AFTER SURGICAL MYOCARDIAL REVASCULARIZATION Abstract  similar documents
A. V. Panov, B. A. Tatarskiy, M. L. Gordeev, R. I. Nilk
"... Aim. To estimate an efficacy of therapy with ω-3 polyunsaturated fatty emacids/em (PUFA) in patients ..."
 
Vol 12, No 3 (2016) CLINICAL AND LABORATORY CHARACTERISTICS OF PATIENTS WITH ISCHEMIC HEART DISEASE RESISTANT TO ACETYLSALICYLIC ACID IN PERIOPERATIVE PERIOD OF CORONARY ARTERY BYPASS GRAFT: RESULTS OF AN OPEN PROSPECTIVE STUDY Abstract  PDF (Eng)  similar documents
Yu. I. Grinshtein, A. A. Kosinova, I. Yu. Grinshtein, A. V. Kovalev, V. G. Sukhovol'skiy, A. A. Savchenko
"... that are sensitive or resistant to acetylsalicylic emacid/em (ASA) before and after coronary artery bypass graft (CABG ..."
 
Vol 15, No 2 (2019) Correction of Hypertriglyceridemia as the Way to Reduce Residual Risk in Diseases Caused by Atherosclerosis. Conclusion of the Advisory Board of the Russian Society of Cardiology, the Russian Scientific Medical Society of Therapists, the Eurasian Association of Therapists, the Russian National Atherosclerosis Society, the Russian Association of Endocrinologists, and the National League of Cardiologic Genetics Abstract  similar documents
G. P. Arutyunov, S. A. Boytsov, M. I. Voyevoda, V. S. Gurevich, O. M. Drapkina, V. V. Kukharchuk, A. I. Martynov, I. V. Sergiyenko, M. V. Shestakova, A. S. Aliyeva, N. M. Akhmedzhanov, M. G. Bubnova, А. S. Galyavich, I. G. Gordeyev, M. V. Ezhov, Yu. A. Karpov, V. O. Konstantinov, S. V. Nedogoda, E. M. Nifontov, Ya. A. Orlova, A. V. Panov, S. A. Sayganov, V. V. Skibitskiy, E. I. Tarlovskaya, S. A. Urazgildeyeva, Yu. Sh. Khalimov
"... polyunsaturated fatty emacid/em can be used in the dosage of 2-4 g daily. In patients with triglyceride level higher ..."
 
Vol 9, No 3 (2013) PROBLEMS AND PROSPECTS OF INTERMEDIARY METABOLISM CORRECTION IN PATIENTS WITH VASCULAR COMORBIDITY Abstract  similar documents
S. A. Rumyantseva, R. G. Oganov, V. A. Stupin, E. V. Silina, A. S. Orlova, S. B. Bolevich, V. V. Afanasev, E. N. Kabaeva, S. A. Volik
"... Disorders of intermediary metabolism in the glycolysis cycles and fatty emacids/em oxidation play ..."
 
Vol 8, No 2 (2012) EFFICACY AND SAFETY OF ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES Abstract  similar documents
S. N. Tolpygina, S. Yu. Martsevich, E. N. Khoseva, N. V. Kiseleva
"... Acetylsalicylic emacid/em (ASA) use in the primary and secondary prevention of cardiovascular diseases ..."
 
Vol 14, No 3 (2018) THE POSSIBILITIES OF USING A NEW FIXED-DOSE COMBINATION OF ROSUVASTATIN AND ACETYLSALICYLIC ACID: FOCUS GROUPS OF PATIENTS Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, N. Yu. Voevodina, S. S. Sharonova
"... are presented. Current data on the pattern of antiplatelet use, including acetylsalicylic emacid/em, in individuals ..."
 
1 - 49 of 49 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)